Cannabis for Aches and Calm: A Practical Guide for 40+

Older adult's hand gently holding an orange ceramic teacup on a table in soft light
Photo by ANTONI SHKRABA production on Pexels

Written by

–

Drafted with AI assistance and reviewed by Kurt Greiner. How we use AI.

For adults 21 and older. Cannabis and hemp-derived cannabinoid laws vary widely by state and municipality; check your local regulations before purchasing.

If you’ve got a sore hand, a stiff knee, or a joint that’s getting worse, you may be wondering whether cannabis products help. Here’s what the evidence supports, what it doesn’t, and how to use them without surprises.

Topicals: the most promising use

In a small randomized trial of people with arthritis at the base of the thumb, a topical CBD gel in shea butter, applied twice daily for two weeks, improved pain and hand function compared with plain shea butter. No adverse events were reported.[1] It was a single-center study of 18 participants, so treat it as promising, not settled.

Topicals aren’t zero-exposure, though. In a 2024 study of five hemp topicals, CBD showed up in the blood and built up over days of twice-daily use, highest with a lotion that contained vitamin E as a skin-penetration enhancer.[2] If you take a blood thinner or other prescription medication, ask your prescribing doctor or pharmacist before using topical CBD products.

Edibles and tinctures: start low, go slow

In a small study of seven regular users, blood THC from commercial edibles peaked between 35 and 90 minutes after eating, and peak levels varied across products.[3] That delay is a known trap. Poison-center reports describe exposures from eating a whole multi-dose product, and researchers have pointed to delayed THC absorption as one driver of rising edible exposures.[4] At one Colorado emergency room, edible-related visits were more often for intoxication (48%) than inhaled-cannabis visits (28%).[5] Start with the lowest dose on the label, wait until past the 90-minute peak window before taking more, and write down what you took and when.

Reading a label

  • Third-party lab report (COA) for that exact batch. A lab the brand owns doesn’t count.
  • A recent test date.
  • A contaminant panel: pesticides, heavy metals, residual solvents, microbes.
  • THC content. Hemp topicals can contain THC. In the same 2024 study, nine of 46 people using lotions, a patch, or a gel had THC in saliva at 2 ng/mL or higher, the level the study cites as the federal workplace-test threshold.[2]
  • Regulatory status. The FDA has approved one cannabis-derived drug, Epidiolex (CBD), a prescription medicine for specific seizure conditions. Other CBD products are not FDA-approved for any condition.[6]

Check your medications first

Oral CBD can slow the liver enzymes that clear many common drugs.[7] Only about 5% of the studies in a 2025 review tested whether this matters in practice. One case report involves warfarin, a blood thinner. In it, a patient starting a prescription seizure medicine containing CBD needed a nearly 20% warfarin dose cut to keep their blood-clotting test in range.[8] Ask your prescriber or pharmacist before using oral CBD if you take any prescription medicine.

What the evidence doesn’t back

Sleep is a popular reason people try cannabis, and the best data so far points the other way. In a Canadian sleep-clinic study of 1,449 adults, people who used cannabis every day for a year or more woke up more during the night, slept less efficiently, and spent more time in light sleep than non-users.[9] Most patients had sleep apnea, and the study can’t show cause, so treat it as a warning sign, not a verdict.

Inflammation is the other popular claim. The largest review so far, 46 studies and 54,382 people, found cannabis use went with higher levels of both inflammation-promoting and inflammation-calming markers, not a clear drop.[10] In the small CBD trials, the inflammation-promoting markers rose slightly, but not in a way the trials could confirm. So “cannabis reduces inflammation” isn’t clearly supported.

On memory, a large US brain-imaging study of 1,003 young adults, ages 22 to 36, found that heavy lifetime cannabis use was linked to lower brain activity during a memory task. The effect was small, showed up on only one of seven tasks, and doesn’t tell us much about people in their 40s and up.[11]

Bottom line

Topicals have the most support so far, from one small trial, for localized joint pain. Oral products call for more care: start low, check your medications, and buy products with a current third-party lab report. If you have a condition, talk to your clinician first.

References

[1] Heineman JT, Forster GL, Stephens KL, Cottler PS, Timko MP, DeGeorge BR Jr. A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis. J Hand Surg Am. 2022 Jul. https://doi.org/10.1016/j.jhsa.2022.03.002 ↑︎

[2] Zamarripa CA, Tilton HE, Lin S, et al. Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products. J Anal Toxicol. 2024. https://doi.org/10.1093/jat/bkae001 ↑︎ a b

[3] Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control. Pharmaceuticals. 2021 Aug. https://doi.org/10.3390/ph14080817 ↑︎

[4] Characterization of edible marijuana product exposures reported to United States poison centers. Clin Toxicol. 2016. https://doi.org/10.1080/15563650.2016.1209761 ↑︎

[5] Monte AA, Shelton SK, Mills E, Saben J, Hopkinson A, Sonn B, et al. Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study. Ann Intern Med. 2019. https://doi.org/10.7326/M18-2809 ↑︎

[6] U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process. https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process ↑︎

[7] Evidence of Potential Drug Interactions Between Cannabidiol and Other Drugs: A Scoping Review to Guide Pharmaceutical Care. Planta Med. 2025 Aug. https://doi.org/10.1055/a-2593-6351 ↑︎

[8] Warfarin dose adjustment required after cannabidiol initiation and titration. Am J Health Syst Pharm. 2020 Oct. https://doi.org/10.1093/ajhp/zxaa268 ↑︎

[9] Velzeboer et al. Chronic cannabis use and sleep architecture: a cross-sectional analysis of polysomnography outcomes in a sleep-clinic cohort. Sleep. 2026 May. https://doi.org/10.1093/sleep/zsaf396 ↑︎

[10] Belvederi Murri M, Guglielmo R, Zizzi F, et al. Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis. Brain Behav Immun. 2026 Jul. https://doi.org/10.1016/j.bbi.2026.106517 ↑︎

[11] Gowin JL, Ellingson JM, Karoly HC et al. Brain Function Outcomes of Recent and Lifetime Cannabis Use. JAMA Netw Open. 2025. https://doi.org/10.1001/jamanetworkopen.2024.57069 ↑︎

Kurt Greiner
Kurt Greiner

Kurt is a digital strategist and IT professional blending emerging technology with practical application, exploring how individuals can leverage modern tools to navigate the second half of life with purpose.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website provides wellness information for educational purposes only. It is not medical advice. Consult a healthcare professional before making any health-related decisions or changes.

Bettering Me Wellness 40+ logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.